newsfilter
← Latest News
Business Wire·

AVROBIO Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

AVROBIO, Inc. (NASDAQ:AVRO), a leading clinical-stage gene therapy company with a mission to free people from a lifetime of genetic disease, today announced that the company has granted a non-statutory stock option for the purchase of up to 22,000 share